{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T11:26:44Z","timestamp":1774783604143,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-026-01696-8","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T07:58:44Z","timestamp":1774771124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fracture liaison services: successful implementation in Belgium using a regional healthcare quality improvement initiative"],"prefix":"10.1007","volume":"21","author":[{"given":"Micha\u00ebl R.","family":"Laurent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Samaey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Kassim","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"key":"1696_CR1","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00198-020-05339-7","volume":"31","author":"L Iconaru","year":"2020","unstructured":"Iconaru L, Smeys C, Baleanu F et al (2020) Osteoporosis treatment gap in a prospective cohort of volunteer women. Osteoporos Int 31:1377\u20131382. https:\/\/doi.org\/10.1007\/s00198-020-05339-7","journal-title":"Osteoporos Int"},{"key":"1696_CR2","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00198-021-05911-9","volume":"32","author":"N Li","year":"2021","unstructured":"Li N, Hiligsmann M, Boonen A et al (2021) The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis. Osteoporos Int 32:1517\u20131530. https:\/\/doi.org\/10.1007\/s00198-021-05911-9","journal-title":"Osteoporos Int"},{"key":"1696_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00198-024-07376-y","volume":"36","author":"C Andreasen","year":"2025","unstructured":"Andreasen C, Dahl C, Frihagen F et al (2025) Fracture liaison service (FLS) is associated with lower subsequent fragility fracture risk and mortality: NoFRACT (the Norwegian capture the fracture initiative). Osteoporos Int 36:501\u2013512. https:\/\/doi.org\/10.1007\/s00198-024-07376-y","journal-title":"Osteoporos Int"},{"key":"1696_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00198-024-07325-9","volume":"36","author":"U Yoel","year":"2025","unstructured":"Yoel U, Alkobi Weiss H, Goldbart A et al (2025) The impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates-a single-center retrospective study. Osteoporos Int 36:299\u2013309. https:\/\/doi.org\/10.1007\/s00198-024-07325-9","journal-title":"Osteoporos Int"},{"key":"1696_CR5","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s00198-015-3192-0","volume":"26","author":"MK Javaid","year":"2015","unstructured":"Javaid MK, Kyer C, Mitchell PJ et al (2015) Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture\u00ae best practice framework tool. Osteoporos Int 26:2573\u20132578. https:\/\/doi.org\/10.1007\/s00198-015-3192-0","journal-title":"Osteoporos Int"},{"key":"1696_CR6","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s00198-023-06759-x","volume":"34","author":"MK Javaid","year":"2023","unstructured":"Javaid MK, Pinedo-Villanueva R, Shah A et al (2023) The Capture the Fracture\u00ae partnership: an overview of a global initiative to increase the secondary fracture prevention care for patient benefit. Osteoporos Int 34:1827\u20131835. https:\/\/doi.org\/10.1007\/s00198-023-06759-x","journal-title":"Osteoporos Int"},{"key":"1696_CR7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00198-019-05197-y","volume":"31","author":"PR Ebeling","year":"2020","unstructured":"Ebeling PR, Chan D-C, Lau TC et al (2020) Secondary prevention of fragility fractures in Asia Pacific: an educational initiative. Osteoporos Int 31:805\u2013826. https:\/\/doi.org\/10.1007\/s00198-019-05197-y","journal-title":"Osteoporos Int"},{"key":"1696_CR8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00198-020-05377-1","volume":"31","author":"MK Javaid","year":"2020","unstructured":"Javaid MK, Sami A, Lems W et al (2020) A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network. Osteoporos Int 31:1193\u20131204. https:\/\/doi.org\/10.1007\/s00198-020-05377-1","journal-title":"Osteoporos Int"},{"key":"1696_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-025-01562-z","volume":"20","author":"\u015e T\u00fcz\u00fcn","year":"2025","unstructured":"T\u00fcz\u00fcn \u015e, Temel MH, Akar\u0131rmak Z\u00dc et al (2025) Digital integration and sociocultural tailoring in standardized care-FracTurk: the national digital fracture liaison service database by the Turkish Osteoporosis Society. Arch Osteoporos 20:70. https:\/\/doi.org\/10.1007\/s11657-025-01562-z","journal-title":"Arch Osteoporos"},{"key":"1696_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-022-01108-7","volume":"17","author":"B Stolnicki","year":"2022","unstructured":"Stolnicki B, In\u00e1cio AM, Tutiya KK et al (2022) How to initiate and develop Fracture Liaison Services (FLS). Recommendations from the IOF Capture the Fracture\u00ae FLS mentors in Brazil. Arch Osteoporos 17:63. https:\/\/doi.org\/10.1007\/s11657-022-01108-7","journal-title":"Arch Osteoporos"},{"key":"1696_CR11","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s00198-023-06742-6","volume":"34","author":"MK Javaid","year":"2023","unstructured":"Javaid MK, Calo M, Wullich S et al (2023) Development, implementation and evaluation of a multinational FLS mentorship programme in Latin America. Osteoporos Int 34:1881\u20131891. https:\/\/doi.org\/10.1007\/s00198-023-06742-6","journal-title":"Osteoporos Int"},{"key":"1696_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2015-004480","volume":"25","author":"D Goodman","year":"2016","unstructured":"Goodman D, Ogrinc G, Davies L et al (2016) Explanation and elaboration of the SQUIRE (Standards for Quality Improvement Reporting Excellence) guidelines, V.2.0: examples of SQUIRE elements in the healthcare improvement literature. BMJ Qual Saf 25:e7. https:\/\/doi.org\/10.1136\/bmjqs-2015-004480","journal-title":"BMJ Qual Saf"},{"key":"1696_CR13","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00198-013-2348-z","volume":"24","author":"K Akesson","year":"2013","unstructured":"Akesson K, Marsh D, Mitchell PJ et al (2013) Capture the fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135\u20132152. https:\/\/doi.org\/10.1007\/s00198-013-2348-z","journal-title":"Osteoporos Int"},{"key":"1696_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/OI9.0000000000000198","volume":"5","author":"TJS Chesser","year":"2022","unstructured":"Chesser TJS, Javaid MK, Mohsin Z et al (2022) Overview of fracture liaison services in the UK and Europe: standards, model of care, funding, and challenges. OTA Int 5:e198. https:\/\/doi.org\/10.1097\/OI9.0000000000000198","journal-title":"OTA Int"},{"key":"1696_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-025-07721-9","author":"Y Takegami","year":"2025","unstructured":"Takegami Y, Imaizumi T, Sato K et al (2025) Impact of a national reimbursement policy on anti-osteoporosis medication prescription at discharge after hip-fracture surgery in Japan: an interrupted time-series analysis. Osteoporos Int. https:\/\/doi.org\/10.1007\/s00198-025-07721-9","journal-title":"Osteoporos Int"},{"key":"1696_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.maturitas.2020.05.006","volume":"139","author":"D Sanchez-Rodriguez","year":"2020","unstructured":"Sanchez-Rodriguez D, Bergmann P, Body JJ et al (2020) The Belgian Bone Club 2020 guidelines for the management of osteoporosis in postmenopausal women. Maturitas 139:69\u201389. https:\/\/doi.org\/10.1016\/j.maturitas.2020.05.006","journal-title":"Maturitas"},{"key":"1696_CR17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00198-024-07043-2","volume":"35","author":"E Gielen","year":"2024","unstructured":"Gielen E, Aldv\u00e9n M, Kanis JA et al (2024) Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium. Osteoporos Int 35:1173\u20131183. https:\/\/doi.org\/10.1007\/s00198-024-07043-2","journal-title":"Osteoporos Int"},{"key":"1696_CR18","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00198-020-05512-y","volume":"31","author":"L Van Camp","year":"2020","unstructured":"Van Camp L, Dejaeger M, Tournoy J et al (2020) Association of orthogeriatric care models with evaluation and treatment of osteoporosis: a systematic review and meta-analysis. Osteoporos Int 31:2083\u20132092. https:\/\/doi.org\/10.1007\/s00198-020-05512-y","journal-title":"Osteoporos Int"},{"key":"1696_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2025.117701","volume":"202","author":"E Gielen","year":"2026","unstructured":"Gielen E, Amini N, Coppens D et al (2026) Bone mineral density response to romosozumab in post-menopausal women: a prospective observational real-world study. Bone 202:117701. https:\/\/doi.org\/10.1016\/j.bone.2025.117701","journal-title":"Bone"},{"key":"1696_CR20","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00198-025-07540-y","volume":"36","author":"M Rippl","year":"2025","unstructured":"Rippl M, Grupp P, Martini S et al (2025) Characteristics and treatment options of 272,152 geriatric patients with very high and high fracture risk. Osteoporos Int 36:1257\u20131266. https:\/\/doi.org\/10.1007\/s00198-025-07540-y","journal-title":"Osteoporos Int"},{"key":"1696_CR21","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s00198-011-1642-x","volume":"22","author":"D Marsh","year":"2011","unstructured":"Marsh D, Akesson K, Beaton DE et al (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22:2051\u20132065. https:\/\/doi.org\/10.1007\/s00198-011-1642-x","journal-title":"Osteoporos Int"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01696-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-026-01696-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01696-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T07:58:45Z","timestamp":1774771125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-026-01696-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1696"],"URL":"https:\/\/doi.org\/10.1007\/s11657-026-01696-8","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript does not contain clinical studies or patient data; ethics approval was not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"MRL has received consultancy and lecture fees from Alexion, A.M. Pharma, Amgen, AstraZeneca, Celltrion, Galapagos, Kyowa Kirin, Menarini, Orifarm, Pharmanovia, Samsung Bioepis, Sandoz, Takeda, Theramex, UCB Pharma, and Will Pharma, outside of the development of this manuscript. PS has received consultancy fees from Amgen, UCB Pharma, and Will Pharma, outside of the development of this manuscript. MKJ is the FAN Steering Committee Co-Chair, has been the co-chair of the Capture the Fracture\u00ae programme, and has received honoraria and grant support from Amgen, UCB Pharma, and Kyowa Kirin outside of the development of this manuscript.The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"58"}}